Clinical Trials Browser

Phase 2 × Leukemia, Biphenotypic, Acute × Tyrosine Kinase Inhibitors × Clear all

NCT04440267 2025-08-06

Efficacy of Acute Lymphoblastic Leukemia-Based Therapy in Treating Patients With Acute Leukemia of Ambiguous Lineage

Phase 2 Recruiting

Other hematologic neoplasm

Leukemia, Biphenotypic, Acute